Detalhe da pesquisa
1.
Clinical course and management of children with IgA vasculitis with nephritis.
Pediatr Nephrol
; 38(11): 3721-3733, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37316676
2.
Acute kidney injury requiring kidney replacement therapy in childhood lupus nephritis: a cohort study of the Pediatric Nephrology Research Consortium and Childhood Arthritis and Rheumatology Research Alliance.
Pediatr Nephrol
; 38(5): 1653-1665, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251074
3.
Skeletal Outcomes in Children and Young Adults with Glomerular Disease.
J Am Soc Nephrol
; 33(12): 2233-2246, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36171052
4.
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan.
Am J Nephrol
; 53(10): 675-686, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36404708
5.
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies.
Am J Nephrol
; 53(10): 687-700, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423588
6.
Ravulizumab 100 mg/mL formulation reduces infusion time and frequency, improving the patient and caregiver experience in the treatment of atypical haemolytic uraemic syndrome.
J Clin Pharm Ther
; 47(7): 1081-1087, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304755
7.
The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Kidney Int
; 100(1): 225-237, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307104
8.
Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research.
J Am Soc Nephrol
; 30(12): 2427-2435, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732612
9.
Corrigendum to "The long-acting C5 inhibitor, ravulizumab, is effective and safe in pediatric patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2021;100:225-237.
Kidney Int
; 104(1): 205, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349053
10.
Primary cilia regulate the osmotic stress response of renal epithelial cells through TRPM3.
Am J Physiol Renal Physiol
; 312(4): F791-F805, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28122715
11.
Improvement in Renal Cystic Disease of Tuberous Sclerosis Complex After Treatment with Mammalian Target of Rapamycin Inhibitor.
J Pediatr
; 187: 318-322.e2, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28600153
12.
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 22(2): 307-315, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26456258
13.
Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy.
Blood
; 122(12): 2003-7, 2013 Sep 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-23814021
14.
Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.
Am J Physiol Renal Physiol
; 307(5): F560-70, 2014 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24920756
15.
Eculizumab therapy in children with severe hematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Biol Blood Marrow Transplant
; 20(4): 518-25, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24370861
16.
Clinical Safety and Efficacy of Pegcetacoplan in a Phase 2 Study of Patients with C3 Glomerulopathy and Other Complement-Mediated Glomerular Diseases.
Kidney Int Rep
; 8(11): 2284-2293, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38025230
17.
Treatment preference and quality of life impact: ravulizumab vs eculizumab for atypical hemolytic uremic syndrome.
J Comp Eff Res
; 12(9): e230036, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37515502
18.
Derivation of paediatric blood pressure percentiles from electronic health records.
EBioMedicine
; 98: 104885, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988770
19.
Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.
Clin J Am Soc Nephrol
; 18(2): 173-182, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754006
20.
The Preserving Kidney Function in Children With CKD (PRESERVE) Study: Rationale, Design, and Methods.
Kidney Med
; 5(11): 100722, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37965485